@inproceedings{inproceedings, title  = {{DUPILUMAB IMPROVES PATIENT-REPORTED OUTCOMES IN ATOPIC DERMATITIS PATIENTS INADEQUATELY CONTROLLED, INTOLERANT, OR INADVISABLE FOR CYCLOSPORINE-A}},

 url = {{}},

 year = {{2017}},

 month = {{1}},

 author = {{De Bruin-Weller M and Gadkari A and Simpson E and Cork M and Puig L and Girolomoni G and Wollenberg A and Chen Z and Radin A and Shumel B and Ardeleanu M et al}},

 volume = {{119}},

 journal = {{ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY}},

 issue = {{5}},

 pages = {{S94-S95}},

 note = {{Accessed on 2024/12/22}}}